Phase I trial of AT 001 for the treatment of metastatic solid tumours
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2012
At a glance
- Drugs Bevacizumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 27 Sep 2012 Status changed from not yet recruiting to recruiting, according to Affitech A/S media release.
- 24 May 2012 Planned initiation date changed from 1 May 2012 to 1 Jun 2012 based on information reported in an Affitech A/S media release.
- 17 Apr 2012 Status changed from planning to not yet recruiting, according to an Affitech A/S media release.